Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05154513 · ClinicalTrials.gov registry record
Long-Term Clinical, Immunologic, and Virologic Profiles of Children Who Received Early Treatment for HIV
A clinical trial, sponsored by International Maternal Pediatric Adolescent AIDS Clinical Trials Group.
- Completed
- Registry status
- 163
- Enrollment target
NCT05154513: Completed study, sponsored by International Maternal Pediatric Adolescent AIDS Clinical Trials Group.
NCT05154513 is a clinical trial that has completed, run by International Maternal Pediatric Adolescent AIDS Clinical Trials Group. The registered enrollment target is 163 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05154513 has completed, sponsored by International Maternal Pediatric Adolescent AIDS Clinical Trials Group.
- COMPLETED
- Registry status
- 163 participants
- Enrollment target
Study Summary
IMPAACT 2028 is an observational prospective study to characterize a cohort of early treated children who may participate in future research related to HIV remission or cure. Up to approximately 250 participants will be in the study for approximately seven years. No intervention is provided in the study.
Primary Outcome
Median and interquartile range; to characterize long-term clinical profile
Interventions
- OTHER Cohort 1
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 163 participants |
| Start Date | 2022-02-02 |
| Est. Completion | 2025-07-30 |
What the finished NCT05154513 record still lists
NCT05154513 is an observational study that tracks outcomes without assigning an intervention. The registered 163 participants enrollment target is mid-sized for trials with a published cap.
The record links to 0 conditions, and to 1 intervention - of which Cohort 1 is the first listed.
NCT05154513 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT05154513 about?
NCT05154513 is a clinical study titled "Long-Term Clinical, Immunologic, and Virologic Profiles of Children Who Received Early Treatment for HIV". IMPAACT 2028 is an observational prospective study to characterize a cohort of early treated children who may participate in future research related to HIV remission or cure. Up to approximately 250 participants will be in the study for approximately seven years. No intervention is provided in the s...
What is the current status of trial NCT05154513?
This trial is currently completed. The enrollment target is 163 participants. The study started on 2022-02-02. Estimated completion is 2025-07-30.
What interventions are being tested in trial NCT05154513?
The interventions under investigation include: Cohort 1 (OTHER).
Who is sponsoring clinical trial NCT05154513?
This trial is sponsored by International Maternal Pediatric Adolescent AIDS Clinical Trials Group, which has 17 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03180268 · 163 participants · Phase 3
Observation or Radiation Therapy in Treating Patients With Newly Diagnosed Grade II Meningioma That Has Been Completely Removed by Surgery
- NCT04862221 · 163 participants · Phase 2
TReatment for ImmUne Mediated PathopHysiology
- NCT05702229 · 163 participants · Phase 2
Novel Combinations in Participants With Locally Advanced Unresectable or Metastatic Gastric or Gastroesophageal Junction Adenocarcinoma
- NCT06137118 · 163 participants · Phase 1
AZD0486 as Monotherapy in B-cell Acute Lymphoblastic Leukaemia
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI